Search results
Results From The WOW.Com Content Network
Iron (II) hydroxide or ferrous hydroxide is an inorganic compound with the formula Fe(OH) 2. It is produced when iron (II) salts, from a compound such as iron(II) sulfate, are treated with hydroxide ions. Iron(II) hydroxide is a white solid, but even traces of oxygen impart a greenish tinge. The air-oxidised solid is sometimes known as "green ...
Lawrencite, (Fe,Ni)Cl 2, is the natural counterpart, and a typically (though rarely occurring) meteoritic mineral. [14] The natural form of the dihydrate is rokühnite - a very rare mineral. [ 15 ] Related, but more complex (in particular, basic or hydrated) minerals are hibbingite , droninoite and kuliginite .
The sulfate salt [Fe(bipy) 3]SO 4 is produced by combining ferrous sulfate with excess bipy in aqueous solution. This result illustrates the preference of Fe(II) for bipyridine vs water. Addition of cyanide to this solution precipitates solid Fe(bipy) 2 (CN) 2. [2]
For example, "ferrous sulfide" can refer to the 1:1 species (mineral name troilite) or a host of Fe-deficient derivatives . The mineral magnetite ("lode stone") is a mixed-valence compound with both Fe(II) and Fe(III), Fe 3 O 4.
Halides are X-type ligands in coordination chemistry.They are both σ- and π-donors. Chloride is commonly found as both a terminal ligand and a bridging ligand.The halide ligands are weak field ligands.
Structure of [Co 2 (OH 2) 10] 4+ color code: red = O, white = H, blue = Co. In the binuclear ion [Co 2 (OH 2) 10] 4+ each bridging water molecule donates one pair of electrons to one cobalt ion and another pair to the other cobalt ion. The Co-O (bridging) bond lengths are 213 picometers, and the Co-O (terminal) bond lengths are 10 pm shorter.
2 [fe(h 2 o) 4 (oh) 2] + ⇌ [fe 2 (h 2 o) 8 (oh) 2] + 2 + 2 h 2 o The aquo ligands on iron(III) complexes are labile. This behavior is visualized by the color change brought about by reaction with thiocyanate to give a deep red thiocyanate complex .
Radium-223 dichloride (USP, radium chloride Ra 223), tradename Xofigo (formerly Alpharadin), is an alpha-emitting radiopharmaceutical. Bayer received FDA approval for this drug to treat prostate cancer osteoblastic bone metastases in May 2013. Radium-223 chloride is one of the most potent ((antineoplastic drugs)) known.